4.8 Article

Cholera

期刊

LANCET
卷 379, 期 9835, 页码 2466-2476

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(12)60436-X

关键词

-

资金

  1. National Institutes of Health [AI058935, U01 AI077883]
  2. Bill & Melinda Gates Foundation
  3. Swedish International Development Agency (Sida)
  4. Charles H Hood Foundation
  5. Howard Hughes Medical Institute
  6. International Centre for Diarrhoeal Research, Dhaka
  7. International Research Scientist Development Award [K01 TW07409]

向作者/读者索取更多资源

Cholera is an acute, secretory diarrhoea caused by infection with Vibrio cholerae of the O1 or O139 serogroup. It is endemic in more than 50 countries and also causes large epidemics. Since 1817, seven cholera pandemics have spread from Asia to much of the world. The seventh pandemic began in 1961 and affects 3-5 million people each year, killing 120 000. Although mild cholera can be indistinguishable from other diarrhoeal illnesses, the presentation of severe cholera is distinct, with pronounced diarrhoeal purging. Management of patients with cholera involves aggressive fluid replacement; effective therapy can decrease mortality from more than 50% to less than 0.2%. Antibiotic treatment decreases volume and duration of diarrhoea by 50% and is recommended for patients with moderate to severe dehydration. Prevention of cholera depends on access to safe water and sanitation. Two oral cholera vaccines are available and the most effective use of these in integrated prevention programmes is being actively assessed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据